|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00001598 |
|
Date of registration:
|
03/11/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
DHEA Treatment for Sjogren's Syndrome
|
|
Scientific title:
|
Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome |
|
Date of first enrolment:
|
May 1997 |
|
Target sample size:
|
28 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00001598 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Females with a diagnosis of Primary Sjogren's Syndrome.
No history of breast cancer.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Sjogren's Syndrome
|
|
Salivary Gland Disease
|
|
Xerostomia
|
|
Lacrimal Apparatus Disease
|
|
Intervention(s)
|
|
Drug: Dehydroepiandrosterone
|
|
Secondary ID(s)
|
|
97-D-0123
|
|
970123
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|